Modeling loss of MLL3 function using shRNA knockdown in the ER+ PIK3CA‐wildtype breast cancer cell line ZR751, we found that knockdown of MLL3 led to a major loss of H3K4me1 marked peaks across the genome. Here, KMT2C is linked to breast carcinoma.